← Back

Corbion NV

Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing product; AlgaVia which develops foods and beverages with reduced saturated fat content; CALFEED, a dry lactic acid source to boost feed intake for swine or poultry; LAFEED that helps feed intake and digestive health; LAFEED Powder that acts as a preservative and acidulate; PURAC DW, provides an acidifier, preservative, and antimicrobial in teat-dip applications for animals; PURAC Pet food; PURASOLV; and PURASOLV EL. It also provides PURASORB polymers for medical and pharmaceutical industries; PURASOLV solvents; PURALACT B3 for resin and coating performance; personal care products, such as ESTERLAC Emulsifiers and Surfactants, GLUCONAL ZN, PURAC BF/P41, PURAC HiPure 90, PURAC UltraPure, PURACAL PP/USP, PURAMEX ZN, PURASAL MOISTXS, PURASAL NH/COS, PURASAL S/HQ60, and PURASOLV EL; and GLUCONAL, PURAC PF, PURACAL, PURAMEX, and PURASAL S/PF. In addition, the company offers food solutions, including acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning and texturizing, and taste and texture; PURASORB R&D; biochemical specialties solutions comprising solvency, antimicrobial, moisturization, and pharma; and Algae ingredients solutions. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1903 and is headquartered in Amsterdam, the Netherlands.

Price · split & dividend adjusted
News & notes moving CRBN.AS
CRBN.AS

Corbion reports Q2 organic sales growth of 8.5% and refines full-year margin outlook to above 16%

Corbion announced second-quarter organic sales growth of 8.5% to €337.4 million and Adjusted EBITDA of €51.0 million, while refining its full-year 2026 Adjusted EBITDA margin outlook to above 16% from approximately 17%. For the first half of 2026, organic sales growth was 2.1% with volume/mix up 4.0% and pricing down 1.9%, resulting in sales of €631.1 million and Adjusted EBITDA of €88.8 million. The company maintained its full-year organic sales growth guidance of 3% to 6% and free cash flow forecast of €85 million to €90 million. CEO Olivier Rigaud cited strong volume/mix momentum in both Functional Ingredients & Solutions and Health & Nutrition, and expects margins to improve in the second half driven by cost savings, price increases, and continued positive volume/mix development.
GlobeNewswire·27dRead more ▾
Biotech & Genomic Medicine

Polymeric Biomaterials Market to Reach USD 267.25 Billion by 2034

The global polymeric biomaterials market is projected to grow from USD 69.55 billion in 2024 to USD 267.25 billion by 2034, at a compound annual growth rate of 15.86%, according to a new report from Zion Market Research. The polylactic acid product segment held a dominant 28% revenue share in 2024, driven by its biodegradability and versatility in applications such as drug delivery and tissue engineering. By application, orthopedics led with a 29% share, fueled by rising demand for joint replacements and bone scaffolds. Asia-Pacific is expected to maintain its leading regional position, supported by healthcare expansion and investments in regenerative medicine in countries like China, Japan, and India. Key companies profiled include BASF, DuPont, Evonik Industries, and Corbion.
GlobeNewswire·69dRead more ▾